Home Newsfeeds Raymond James Downgrades Continental Resources to Market Perform

Raymond James Downgrades Continental Resources to Market Perform

Raymond James analyst John Freeman downgrades Continental Resources (NYSE:CLR) from Outperform to Market Perform.

byBenzinga Newsdesk

October 24, 2022

1 minute read

Raymond James analyst John Freeman downgrades Continental Resources (NYSE:CLR) from Outperform to Market Perform.

Analyst Ratings

Analyst Ratings for Cocrystal Pharma

By Benzinga Insights

August 15, 3:00 PM

Cocrystal Pharma (NASDAQ:COCP) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

COCP

ClearPoint Neuro Congratulates Its Partner AviadoBio On First Patient Treated In Its ASPIRE-FTD Clinical Trial Evaluating AVB-101 For Frontotemporal Dementia With GRN Mutations

By Benzinga Newsdesk

April 16, 4:23 PM

ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today congratulates its partner AviadoBio on treating its

CLPT

Benzinga’s Top Ratings Upgrades, Downgrades For October 12, 2022

By Benzinga Insights

October 12, 10:02 AM

Upgrades

ABT

Curaleaf Acquires Deseret Wellness

By Vuk Zdinjak

April 10, 8:17 AM

Curaleaf Holdings, Inc. (CSE:CURA) (OTCQX: CURLF) announced the completion of its acquisition of Deseret Wellness. With the close of the transaction, Curaleaf's retail footprint has increased to four dispensaries in Utah and 150 nationwide.

CSE:CURA

Raymond James Downgrades Continental Resources to Market Perform

Related Posts

Analyst Ratings for Cocrystal Pharma

ClearPoint Neuro Congratulates Its Partner AviadoBio On First Patient Treated In Its ASPIRE-FTD Clinical Trial Evaluating AVB-101 For Frontotemporal Dementia With GRN Mutations

Benzinga’s Top Ratings Upgrades, Downgrades For October 12, 2022

Curaleaf Acquires Deseret Wellness